Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids.


Autoria(s): Gabutti L.; Salvadé I.; Lucchini B.; Soldini D.; Burnier M.
Data(s)

01/04/2011

Resumo

BACKGROUND: A rapid decrease of serum potassium concentrations during haemodialysis produces a significant increase in blood pressure parameters at the end of the session, even if effects on intra-dialysis pressure are not seen. Paradoxically, in animal models potassium is a vasodilator and decreases myocardial contractility. The purpose of this trial is to study the precise haemodynamic consequences induced by acute changes in potassium concentration during haemodialysis. METHODS: In 24 patients, 288 dialysis sessions, using a randomised single blind crossover design, we compared six dialysate sequences with different potassium profiles. The dialysis sessions were divided into 3 tertiles, casually modulating potassium concentration in the dialysate between the value normally used K and the two cut-off points K+1 and K-1 mmol/l. Haemodynamics were evaluated in a non-invasive manner using a finger beat-to-beat monitor. RESULTS: Comparing K-1 and K+1, differences were found within the tertiles regarding systolic (+5.3, +6.6, +2.3 mmHg, p < 0.05, < 0.05, ns) and mean blood pressure (+4.3, +6.4, -0.5 mmHg, p < 0.01, < 0.01, ns), as well as peripheral resistance (+212, +253, -4 dyne.sec.cm-5, p < 0.05, < 0.05, ns). The stroke volume showed a non-statistically-significant inverse trend (-3.1, -5.2, -0.2 ml). 18 hypotension episodes were recorded during the course of the study. 72% with K-1, 11% with K and 17% with K+1 (p < 0.01 for comparison K-1 vs. K and K-1 vs. K+1). CONCLUSIONS: A rapid decrease in the concentration of serum potassium during the initial stage of the dialysis-obtained by reducing the concentration of potassium in the dialysate-translated into a decrease of systolic and mean blood pressure mediated by a decrease in peripheral resistance. The risk of intra-dialysis hypotension inversely correlates to the potassium concentration in the dialysate. TRIAL REGISTRATION NUMBER: NCT01224314.

Identificador

https://serval.unil.ch/?id=serval:BIB_655A020669E3

isbn:1471-2369 (Electronic)

pmid:21470404

doi:10.1186/1471-2369-12-14

isiid:000304357500001

http://my.unil.ch/serval/document/BIB_655A020669E3.pdf

http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_655A020669E35

Idioma(s)

en

Direitos

info:eu-repo/semantics/openAccess

Fonte

Bmc Nephrology, vol. 12, pp. 14

Palavras-Chave #Blood Pressure/drug effects; Cross-Over Studies; Female; Hemodialysis Solutions/chemistry; Hemodialysis Solutions/pharmacology; Humans; Hypotension/physiopathology; Male; Potassium/blood; Potassium/pharmacology; Renal Dialysis/methods; Stroke Volume/drug effects; Vascular Resistance/drug effects
Tipo

info:eu-repo/semantics/article

article